Ophthalmology News and Research

RSS

Ophthalmology is the specialized field of medicine that focuses on the health of the eye. It includes the anatomy, physiology and diseases that may affect the eye. Historically, the science of ophthalmology encompassed all aspects of visual function, both in health and in illness. Additionally, ophthalmology also includes animal eyes as ocular function and optic diseases are similar among humans and animals.

FGF proteins play broad roles in wound healing

Mice missing two important proteins of the vascular system develop normally and appear healthy in adulthood, as long as they don't become injured. If they do, their wounds don't heal properly, a new study shows.

19 Aug 2014

New contact lens microbiology workshop aims at preventing Acanthamoeba keratitis

The American Academy of Ophthalmology today announced a contact lens microbiology workshop on Sept. 12 aimed at preventing Acanthamoeba keratitis, a rare infection among contact lens wearers that causes severe eye pain, redness, light sensitivity and potential vision loss.

18 Aug 2014

ITS develops new T cell vaccine to protect humans from seasonal and pandemic influenza A

Immune Targeting Systems, specializing in the development of novel T cell immune therapies, has been developing an exciting new T cell vaccine (FlunisynTM) designed to protect humans from all strains of seasonal and pandemic influenza A.

18 Aug 2014

Majority of adults need to double consumption of fruits and vegetables for crucial nutrition, health benefits

New research published in the September issue of the British Journal of Nutrition and featured in the just released Global Phytonutrient Report highlights a significant shortfall in fruit and vegetable consumption in people's diets around the world.

12 Aug 2014

Retina's Alpha IMS microchip receives NUB innovation status from Germany statutory health insurance

Retina Implant AG, the leading developer of subretinal implants for patients blinded by retinitis pigmentosa (RP), today announced that the Company's Alpha IMS microchip was granted NUB innovation status and will now be reimbursed by Germany's statutory health insurance system.

11 Aug 2014

European Commission approves EYLEA Injection for treatment of visual impairment due to DME

Regeneron Pharmaceuticals, Inc. today announced that EYLEA® (aflibercept) Injection has been approved by the European Commission for the treatment of visual impairment due to Diabetic Macular Edema.

11 Aug 2014

Auxilium Pharmaceuticals' total revenues decrease 17% to $83 million in Q2 2014

Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, today announced financial results for the second quarter ending June 30, 2014. The Company highlighted important corporate, commercial, regulatory and clinical development updates from the quarter.

7 Aug 2014

Study shows new potential mechanism to better understand AD in African Americans

Researchers from Boston University School of Medicine report that two rare variants in the AKAP9 gene significantly increase the risk of Alzheimer's disease (AD) in African-Americans.

4 Aug 2014

Researchers create most detailed molecular map for region associated with blinding diseases

Understanding eye diseases is tricky enough. Knowing what causes them at the molecular level is even more confounding.

3 Aug 2014

FDA approves EYLEA Injection for treatment of Diabetic Macular Edema

Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved EYLEA (aflibercept) Injection for the treatment of Diabetic Macular Edema (DME).

29 Jul 2014

PLXNA4 gene may increase risk of developing Alzheimer's disease

Researchers from Boston University School of Medicine report variants in a new gene, PLXNA4, which may increase the risk of developing Alzheimer's disease (AD). The discovery of this novel genetic association may lead to new drug treatment options that target PLXNA4 specifically.

28 Jul 2014

Robert E. Marc named recipient of 2014 Paul Kayser International Award in Retina Research

Robert E. Marc, Ph.D., director of research at the University of Utah's John A. Moran Eye Center, has been named by the International Society of Eye Research as the recipient of the Houston, Texas-based Retina Research Foundation's 2014 Paul Kayser International Award in Retina Research.

23 Jul 2014

Early stage AMD can occur much earlier than previously thought

It is widely accepted that age-related macular degeneration (AMD) is the most common cause of visual impairment and blindness in industrialized countries.

22 Jul 2014

Study shows correlation between education and nearsightedness

Education and behavior have a greater impact on the development of nearsightedness than do genetic factors: With each school year completed, a person becomes more nearsighted.

22 Jul 2014

Iodine supplement can reduce central foveal swelling in RP patients with CME

Cystoid macular edema (CME) is a common complication of retinitis pigmentosa (RP), a family of retinal diseases in which patients typically lose night and side vision first and then develop impaired central vision. CME can also decrease central vision.

22 Jul 2014

Mount Sinai Hospital earns top rankings on the U.S. News & World Report's Best Hospitals Honor Roll

By earning "top rankings" in six out of 16 medical specialties, The Mount Sinai Hospital achieved "Honor Roll" status in this year's U.S. News & World Report "Best Hospitals" guidebook.

16 Jul 2014

Advanced Cell Diagnostics’ in situ hybridization technology reaches two major milestones

Advanced Cell Diagnostics Inc. (ACD), a leader in the field of molecular pathology and developer of cell and tissue-based analysis tools, has announced that its RNAscope® RNA in situ hybridization technology has reached two major milestones. In just three years, over 100 peer-reviewed papers featuring the technology have been published, and with the significant increase in use of RNAscope, ACD has now built a library of over 4000 target probes for numerous species. Probes are designed to order in under two weeks, and in just six months the library has grown by over 1500, reflecting the wide interest in ACD’s breakthrough technology.

From Advanced Cell Diagnostics 15 Jul 2014

DARPins could revolutionize protein therapeutics

Integrating an INTEGRA VIAFLO 96 multichannel pipette into their high throughput expression facility has enabled Molecular Partners (Zurich, Switzerland) to streamline the discovery and development of a novel class of targeted protein therapeutics termed DARPins.

From INTEGRA Biosciences 15 Jul 2014

Acute glaucoma is largely an inflammatory disease, say researchers

Researchers at the University of California, San Diego School of Medicine and Sun Yat-sen University in China have shown that acute glaucoma in mice is largely an inflammatory disease and that high pressure in the eye causes vision loss by setting in motion an inflammatory response similar to that evoked by bacterial infections.

14 Jul 2014

Cataract surgery for people with dementia slows cognition decline, improves quality of life

Cataract surgery for people with Alzheimer's disease and other dementias not only improves vision but can slow decline in cognition and improve quality of life for both people with the disease and their caregivers, according to clinical trial results reported today at the Alzheimer's Association International Conference 2014 (AAIC 2014) in Copenhagen.

13 Jul 2014

Ophthalmology News and Research

Further Reading

FGF proteins play broad roles in wound healing

New contact lens microbiology workshop aims at preventing Acanthamoeba keratitis

ITS develops new T cell vaccine to protect humans from seasonal and pandemic influenza A

Majority of adults need to double consumption of fruits and vegetables for crucial nutrition, health benefits

Retina's Alpha IMS microchip receives NUB innovation status from Germany statutory health insurance

European Commission approves EYLEA Injection for treatment of visual impairment due to DME

Auxilium Pharmaceuticals' total revenues decrease 17% to $83 million in Q2 2014

Study shows new potential mechanism to better understand AD in African Americans

Researchers create most detailed molecular map for region associated with blinding diseases

FDA approves EYLEA Injection for treatment of Diabetic Macular Edema

PLXNA4 gene may increase risk of developing Alzheimer's disease

Robert E. Marc named recipient of 2014 Paul Kayser International Award in Retina Research

Early stage AMD can occur much earlier than previously thought

Study shows correlation between education and nearsightedness

Iodine supplement can reduce central foveal swelling in RP patients with CME

Mount Sinai Hospital earns top rankings on the U.S. News & World Report's Best Hospitals Honor Roll

Advanced Cell Diagnostics’ in situ hybridization technology reaches two major milestones

DARPins could revolutionize protein therapeutics

Acute glaucoma is largely an inflammatory disease, say researchers

Cataract surgery for people with dementia slows cognition decline, improves quality of life

Event guide: The 4th Ophthalmic Drug Delivery Summit eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News